Related Experiment Videos
The Lynch syndrome: a management dilemma
Piergaspare Palumbo1, Chiara Amatucci, Bruno Perotti
1"R. Paolucci" Department of Surgery, The University of Rome "La Sapienza", Viale del Policlinico 155, 00161 Rome, Italy. piergaspare.palumbo@uniroma1.it.
Anticancer Research
|May 7, 2013
Summary
Lynch syndrome, a genetic condition causing mismatch repair gene mutations, increases cancer risk. Early diagnosis and yearly surveillance, including clinical exams and endoscopy, are crucial for managing this hereditary cancer predisposition.
Area of Science:
- Genetics
- Oncology
- Hereditary Cancer Syndromes
Background:
- Lynch syndrome is an autosomal dominant condition caused by germline mutations in DNA mismatch repair (MMR) genes.
- It significantly increases the risk of colorectal cancer (CRC) and other extracolonic malignancies.
- Understanding the genetic basis is key for early detection and management.
Observation:
- A familial case of Lynch syndrome is presented, highlighting its hereditary nature.
- Affected family members developed colorectal cancer and other neoplasms.
- Genetic confirmation of the syndrome was achieved through appropriate workup.
Findings:
- Germline mutations in MMR genes underlie Lynch syndrome.
- Carriers exhibit a predisposition to developing various cancers, notably colorectal cancer.
- The study confirmed the syndrome within a family, identifying affected individuals.
Implications:
- Early diagnosis and genetic testing are vital for Lynch syndrome identification.
- Annual clinical examinations and endoscopic surveillance are recommended for high-risk individuals.
- Establishing standardized yearly follow-up protocols can improve management and outcomes for Lynch syndrome patients.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...